Current Topics in Addiction Medicine
Registration |
---|
If you have questions, please email Kristina Seier. |
Learning Objectives
- Develop a framework for managing opioid use disorder, given the increased complexity of fentanyl use.
- Describe best practices for managing stimulant use disorder.
- Recognize emerging intoxicants and understand the basics of treatment.
Speaker
Alexander Hubbell, MD
Addiction Medicine, Minnesota Fairview Health
Education
- Medical School, MD: University of Iowa Roy J. and Lucille A. Carver College of Medicine
- Residency, Family Medicine: University of Minnesota-North Memorial Family Medicine Program
- Fellowship, Addiction Medicine: University of Minnesota Medical Center
Board Certifications
- American Board of Preventive Medicine
- American Board of Family Medicine
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences (DMU) and the Iowa Medical Society. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University Medicine and Health Sciences is Iowa Board of Nursing approved provider #112. This activity has been reviewed and approved for 1.0 continuing education contact hour(s). No partial credit is awarded.
- Other Healthcare Professionals: This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Educational Grants
No ineligible company provided financial support for this continuing education activity.
Disclosures
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Lori Byrd, MS - Activity Director and Planning Committee Member
- Alexander Hubbell, MD - Speaker
- Ryan Roberts - Planning Committee Member
- Kristina Seier, LMSW - Activity Director
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)
- 1.00 IBON